1 Chen W,Zheng R,Zeng H,et al.Annual report on status of cancer in China,2011[J].Chin J Cancer Res,2015,27(1):2-12. 2 Hu L,Duan YT,Li JF,et al.Biglycan enhances gastric cancer invasion by activating FAK signaling pathway[J].Oncotarget,2014,5(7):1885-1896. 3 Zhu YH,Yang F,Zhang SS,et al.High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma[J].Int J Clin Exp Pathol,2013,6(11):2497-505. 4 Liu Y,Li W,Li X,et al.Expression and significance of biglycan in endometrial cancer[J].Arch Gynecol Obstet,2014,289(3):649-655. 5 Gu X,Ma Y,Xiao J,et al.Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers[J].Clin Exp Med,2012,12(3):195-199. 6 Yamamoto K,Ohga N,Hida Y,et al.Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells[J].Br J Cancer,2012,106(6):1214-1223. 7 Wang B,Li GX,Zhang SG,et al.Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer[J].Exp Biol Med(Maywood),2011,236(11):1247-1253. 8 王惠文,刘瑞宝,刘岩,等.乙肝病毒感染性肝癌经TACE后Caspase-3与FAK的表达及意义[J].实用肿瘤学杂志,2011,25(1):49-52. 9 刘丽,王进,杨丽敏.FAK、P-FAK(Y397)、PTEN在胃腺癌组织中的表达及临床意义[J].实用医学杂志,2011,27(2):235-237. 10 Grisaru-Granovsky S,Salah Z,Maoz M,et al.Differential expression of protease activated receptor 1(Par1)and pY397FAK in benign and malignant human ovarian tissue samples[J].Int J Cancer,2005,113(3):372-378. 11 Feng Y,Zhou HX,Li JH,et al.Expression of deleted in liver cancer 1 and phosphorelated focal adhesion kinase in breast cancer[J].Nan Fang Yi Ke Da Xue Xue Bao,2011,31(8):1448-1451. 12 Megison ML,Stewart JE,Nabers HC,et al.FAK inhibition decreases cell invasion,migration and metastasis in MYCN amplified neuroblastoma[J].Clin Exp Metastasis,2013,30(5):555-568. 13 Lei K,Ye L,Yang Y,et al.RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human colon carcinoma xenograft in nude mice[J].J Biomed Nanotechnol,2010,6(3):272-278. |